Objective: To report detailed motor conduction findings on Fisher syndrome (FS). Methods: We retrospectively reviewed motor conduction findings of 55 patients with pure FS and compared them with those obtained from 83 age- and sex-matched healthy volunteers. Results: In the FS group, distal and F-wave latencies of the median, ulnar, peroneal and tibial nerves were all significantly prolonged; motor conduction velocities were slowed in the median, ulnar and peroneal nerves. Conversely, an abnormally low compound muscle action potential amplitude was found only in the median and tibial nerves. Among the four parameters, distal and F-wave latencies were more frequently encountered abnormalities. None of our patients had abnormal temporal dispersion in any motor nerve. Focal involvement of the ulnar nerve across the elbow segment was observed in 6 patients (11%). Of the 55 FS patients, 31 (56%) had abnormal motor conduction results in at least one nerve. Abnormal motor conduction results were noted in 43 and 61% of patients when the tests were performed in the first week and 1 week after onset of FS, respectively (p = 0.238). Conclusion: Our results confirmed that mild motor conduction abnormalities were noted in pure FS, with a pattern similar to those observed in Guillain-Barré syndrome.

Keywords:
Fisher syndrome, Guillain-Barré syndrome, Motor conduction study, Distal latency
1.
Fisher M: An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
2.
Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST: Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997;63:494-500.
3.
Guiloff RL: Peripheral nerve conduction in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 1977;40:801-807.
4.
Sauron B, Bouche P, Cathala H-P, Chain F, Castaigne P: Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology 1984;34:953-956.
5.
Fross RD, Daube JR: Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37:1493-1498.
6.
Jamal GA, Ballantyne JP: The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome): a serial multimodal neurophysiological study. Brain 1988;111(pt 1):95-114.
7.
Lyu RK, Chang KH, Chu CC, Kuo HC, Ro LS: Sensory conduction study in Fisher syndrome: patterns of abnormalities and their clinical correlation. Eur Neurol 2013;70:27-32.
8.
Funakoshi K, Kuwabara S, Odaka M, Hirata K, Yuki N: Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome. J Neurol Neurosurg Psychiatry 2009;80:60-64.
9.
Lyu RK, Huang YC, Wu YR, Kuo HC, Ro LS, Chen CM, Chang HS: Electrophysiological features of Hirayama disease. Muscle Nerve 2011;44:185-190.
10.
Chaudhry V, Clawson LL: Entrapment of motor nerves in motor neuron disease: does double crush occur? J Neurol Neurosurg Psychiatry 1997;62:71-76.
11.
Albers JW, Donofrio PD, McGonagle TK: Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8:528-539.
12.
de Pablos C, Calleja J, Fernández F, Berciano J: Miller Fisher syndrome: an electrophysiologic case study. Electromyogr Clin Neurophysiol 1988;28:21-25.
13.
Gordon PH, Wilbourn AJ: Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol 2001;58:913-917.
14.
Kimura J: Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice, ed 3. New York, Oxford UP, 2001.
15.
Arányi Z, Kovács T, Sipos I, Bereczki D: Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol 2012;19:15-20.
16.
Umapathi T, Tan EY, Kokubun N, Verma K, Yuki N: Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J Neurol Neurosurg Psychiatry 2012;83:941-948.
17.
Brown WF, Snow R: Patterns and severity of conduction abnormalities in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1991;54:768-774.
18.
Kuwabara S, Mori M, Ogawara K, Mizobuchi K, Hattori T, Koga M, Yuki N: Axonal involvement at the common entrapment sites in Guillain-Barré syndrome with IgG anti-GM1 antibody. Muscle Nerve 1999;22:840-845.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.